Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening

被引:19
|
作者
Gies, Anton [1 ,2 ,3 ]
Cuk, Katarina [4 ]
Schrotz-King, Petra [1 ,2 ]
Brenner, Hermann [1 ,2 ,4 ,5 ]
机构
[1] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany
[2] Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[3] Heidelberg Univ, Med Fac Heidelberg, Heidelberg, Germany
[4] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[5] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
关键词
OCCULT BLOOD-TESTS; DIAGNOSTIC PERFORMANCE; AMBIENT-TEMPERATURE; SAMPLE RETURN; METAANALYSIS; POPULATION; TRIAL; RATES;
D O I
10.1038/s41424-018-0035-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: To systematically investigate and directly compare, for the first time, the sample stability of a large number of quantitative fecal immunochemical tests (FITs) at different storage conditions. Methods: Stool samples were obtained from participants of the German screening colonoscopy program between 2005 and 2010. After an initial FIT-based hemoglobin (Hb) measurement, stool samples were kept frozen at -80 degrees C until analysis. Twenty randomly selected participants with initial measurements ranging from 10 to 100 mu g Hb/g feces were included. Ten quantitative FITs were investigated in parallel. A defined stool amount was extracted using each manufacturer's brand-specific fecal sampling device and stored at 5 degrees C, 20 degrees C, and 35 degrees C, respectively. After 1, 4, 5, and 7 days, the samples were analyzed blinded. Median fecal Hb concentrations and positivity rates were calculated. Results: Mean age of the participants was 67 years (range: 56-80 years) and 60% were male. The most advanced finding at screening colposcopy was advanced adenoma in five and non-advanced adenoma in eight cases. Hyperplastic polyps were found in two participants and five participants were without any findings. At 5 degrees C storage temperature, almost all FITs showed fairly stable results throughout the 7-day observation period. At 20 degrees C, most FITs still showed fairly stable results over 4 days, whereas positivity rates significantly declined from day 4 on for most FITs at 35 degrees C. Major differences regarding the sample stability between FITs were observed. Conclusion: FIT-specific Hb decay according to ambient temperature and time period between sampling and test evaluation requires careful consideration in the design of FIT-based screening programs.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Difference in Performance of Fecal Immunochemical Tests With the Same Hemoglobin Cutoff Concentration in a Nationwide Colorectal Cancer Screening Program
    Chiang, Tsung-Hsien
    Chuang, Shu-Lin
    Chen, Sam Li-Sheng
    Chiu, Han-Mo
    Yen, Amy Ming-Fang
    Chiu, Sherry Yueh-Hsia
    Fann, Jean Ching-Yuan
    Chou, Chu-Kuang
    Lee, Yi-Chia
    Wu, Ming-Shiang
    Chen, Hsiu-Hsi
    GASTROENTEROLOGY, 2014, 147 (06) : 1317 - 1326
  • [22] Quantitation of Hemoglobin Improves Fecal Immunochemical Tests for Noninvasive Screening
    Fraser, Callum G.
    Allison, James E.
    Young, Graeme P.
    Halloran, Stephen P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) : 839 - 840
  • [23] Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
    Amitay, Efrat L.
    Gies, Anton
    Weigl, Korbinian
    Brenner, Hermann
    CANCERS, 2019, 11 (03):
  • [24] GUAIAC AND IMMUNOCHEMICAL TESTS FOR FECAL OCCULT BLOOD IN COLORECTAL-CANCER SCREENING
    CASTIGLIONE, G
    GRAZZINI, G
    CIATTO, S
    BRITISH JOURNAL OF CANCER, 1992, 65 (06) : 942 - 944
  • [25] Compliance with fecal immunochemical tests for colorectal cancer screening: A prospective cohort study
    Ching, Jessica Y. L.
    Wong, Martin C. S.
    Tsoi, Kelvin K. F.
    Lam, Thomas Y. T.
    Luk, Arthur K. C.
    Hirai, Hoyee W.
    Griffiths, Sian M.
    Chan, Francis K. L.
    Sung, Joseph J. Y.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 197 - 197
  • [26] Reducing Rejected Fecal Immunochemical Tests Received in the Laboratory for Colorectal Cancer Screening
    Cheng, Caleb
    Ganz, David A.
    Chang, Evelyn T.
    Huynh, Alexis
    De Peralta, Shelly
    JOURNAL FOR HEALTHCARE QUALITY, 2019, 41 (02) : 75 - 82
  • [27] Risk-Adapted Cutoffs in Colorectal Cancer Screening by Fecal Immunochemical Tests
    Peng, Le
    Balavarca, Yesilda
    Niedermaier, Tobias
    Weigl, Korbinian
    Hoffmeister, Michael
    Brenner, Hermann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (07): : 1110 - 1116
  • [28] Advantage of Fecal MicroRNA Combination With Immunochemical Hemoglobin Test for Screening Colorectal Cancer Reply
    Castells, Antoni
    Gironella, Meritxell
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : E642 - E643
  • [29] A Stable and Quantitative Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening
    Clampett, Daniel
    Quindere, Josie
    GASTROENTEROLOGY, 2013, 144 (05) : S601 - S601
  • [30] Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening
    Rabeneck, Linda
    Rumble, R. Bryan
    Thompson, Frank
    Mills, Michael
    Oleschuk, Curtis
    Whibley, Alexandra
    Messersmith, Hans
    Lewis, Nancy
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (03) : 131 - 147